In experiments using mice and liver tissue from humans, Duke researchers identified how the aging process prompts certain liver cells to die off. They were then able to reverse the process in the animals with an investigational drug.

Barton F. Haynes, MD, HS’73-’75, is the Frederic M. Hanes Distinguished Professor of Medicine, professor of integrative immunology and global health and, for 34 years, director of the Duke Human Vaccine Institute (DHVI). He is an internationally recognized researcher who has expanded our understanding of fundamental immune regulation and its role in disease pathogenesis and vaccine development. Haynes’s early work on the biology of the thymus led to discoveries with Louise Markert, PhD’81, MD’82, HS’82-’87, that enabled successful thymus transplantation in children born without a thymus.

Denise Jamieson, MD'92, MPH, is vice president for medical affairs and dean of the Carver College of Medicine at the University of Iowa.

Emily Wang, MD'03, is a professor of internal medicine and public health at the Yale School of Medicine and Yale School of Public Health.

Sarah Wilson, PhD, always had an interest in fighting for justice and fairness, starting as early as high school. That drive to address inequities experienced by people in various communities still exists today. An assistant professor in psychiatry & behavioral sciences at Duke, she is involved with several projects, including a new intervention to mitigate racial implicit bias in clinicians.

In a column posted by American Scientist magazine, Duke Executive Vice President for Health Affairs and School of Medicine Dean Mary E. Klotman, MD; Adjunct Professor in Medicine Brian Southwell, PhD; and Tuckson Health Connections Managing Director Reed V. Tuckson address concerns about the increasing number of Americans who are declining even routine vaccinations due to medical misinformation and other factors.

Clayton Alfonso, MD, an assistant professor of obstetrics and gynecology, strives to make sure everyone who enters his exam room feels welcome and respected and receives evidence-based care.

Groundbreaking research from Duke-NUS offers new hope to millions with asthma and severe food allergies, signaling a new strategy for the prevention of life-threatening reactions.

Kenneth Poss, PhD, is the James B. Duke Distinguished Professor of Regenerative Biology in the Department of Cell Biology at Duke University School of Medicine

Tony Coles, MD’86, has served since 2018 as chair of the board of directors for Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neurological diseases.